Open AccessVirological findings from the SARA trial: boosted PI monotherapy as maintenance second‐line ART in Africa
Author(s) -
Pillay D,
Goodall R,
Gilks CF,
Yirrell D,
Gibb D,
Spyer M,
Kaleebu P,
Munderi P,
Kityo C,
McCormick A,
Nkalubo J,
Lyagoba F,
Chirara M,
Hakim J
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-o20
Subject(s) - medicine , lopinavir , regimen , viral load , tolerability , ritonavir , second line , surrogate endpoint , randomized controlled trial , first line , intention to treat analysis , antiretroviral therapy , human immunodeficiency virus (hiv) , virology , adverse effect
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK